The German pulp and paper industry faces a raft of challenges. Like all energy-intensive industries, it has to manage the vast uncertainty surrounding the shift to renewable energy. Luckily, the legislature has introduced partial exemptions from the EE G surcharge and other tax benefits. If ... more
To stay competitive, pharmaceutical companies have to explore every cost-cutting opportunity. They have already made some progress by outsourcing research, development, contract manufacturing and administrative non-core business processes to established partners.
Infrastructure processes of ... more
Central Europe and Germany are on the verge of collapse. Criticisms of the overall economy automatically trickle down to the chemical and pharmaceutical industry: Wage costs are too high. Skilled workers too scarce. Enviromental regulations too strict. Business space too expensive. Energy c ... more
New medicines and diagnostics on the one hand and rising cost pressure as a result, for example, of the launch of generics and biosimilars on the other mean that new, highly efficient
methods are required in biopharmaceutical production. In order to meet these challenges, Sartorius Stedim B ... more
The integrity testing of sterile filters constitutes a critical and mandatory regulatory step in biopharmaceutical production processes. However, performing such filter integrity tests costs time. Indeed, it can take a good 20 to 30 minutes to perform a diffusion test, bubble-point test or ... more